Cargando…

The role of adipose tissue and adipokines in the manifestation of type 2 diabetes in the long-term period following myocardial infarction

BACKGROUND: This study aimed to evaluate the markers of insulin resistance and adipokine status in patients with visceral obesity during hospitalization following myocardial infarction (MI) and assess the disturbances of carbohydrate metabolism present 1 year after MI onset. METHODS: 94 male patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Barbarash, Olga, Gruzdeva, Olga, Uchasova, Evgenya, Dyleva, Yulia, Belik, Ekaterina, Akbasheva, Olga, Karetnikova, Victoria, Kokov, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794814/
https://www.ncbi.nlm.nih.gov/pubmed/26989445
http://dx.doi.org/10.1186/s13098-016-0136-6
_version_ 1782421526316843008
author Barbarash, Olga
Gruzdeva, Olga
Uchasova, Evgenya
Dyleva, Yulia
Belik, Ekaterina
Akbasheva, Olga
Karetnikova, Victoria
Kokov, Alexander
author_facet Barbarash, Olga
Gruzdeva, Olga
Uchasova, Evgenya
Dyleva, Yulia
Belik, Ekaterina
Akbasheva, Olga
Karetnikova, Victoria
Kokov, Alexander
author_sort Barbarash, Olga
collection PubMed
description BACKGROUND: This study aimed to evaluate the markers of insulin resistance and adipokine status in patients with visceral obesity during hospitalization following myocardial infarction (MI) and assess the disturbances of carbohydrate metabolism present 1 year after MI onset. METHODS: 94 male patients with MI were recruited. The exclusion criteria were as follows: age less than 50 or greater than 80 years, the presence of type 2 diabetes mellitus (T2DM), and a prior history of pronounced renal failure.Obesity types were defined according to body mass index (BMI), waist circumference (WC) and visceral adipose tissue (VAT) area. Glucose, insulin, adiponectin, leptin, and insulin resistance (IR) index were measured on days 1 and 12 after the onset of MI. New-onset type 2 diabetes was assessed 1 year after MI onset. RESULTS: According to computed tomography assessments of all study patients, 69 % of patients with MI suffered from visceral obesity. The VAT area was more closely associated with the risk of developing type 2 diabetes compared with the obesity parameters, BMI and WC. Patients with a VAT area greater than 130 cm(2) had a 3.6-fold higher risk of developing type 2 diabetes. The presence of IR and hyperleptinemia increased the risk of developing diabetes in the post-MI period 3.5 and 3.7 times, respectively, in patients with visceral obesity compared with patients without visceral obesity. CONCLUSION: Visceral obesity is associated with IR, a 5.7-fold increase in leptin levels and a high risk of developing type 2 diabetes 1 year after MI onset.
format Online
Article
Text
id pubmed-4794814
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-47948142016-03-17 The role of adipose tissue and adipokines in the manifestation of type 2 diabetes in the long-term period following myocardial infarction Barbarash, Olga Gruzdeva, Olga Uchasova, Evgenya Dyleva, Yulia Belik, Ekaterina Akbasheva, Olga Karetnikova, Victoria Kokov, Alexander Diabetol Metab Syndr Research BACKGROUND: This study aimed to evaluate the markers of insulin resistance and adipokine status in patients with visceral obesity during hospitalization following myocardial infarction (MI) and assess the disturbances of carbohydrate metabolism present 1 year after MI onset. METHODS: 94 male patients with MI were recruited. The exclusion criteria were as follows: age less than 50 or greater than 80 years, the presence of type 2 diabetes mellitus (T2DM), and a prior history of pronounced renal failure.Obesity types were defined according to body mass index (BMI), waist circumference (WC) and visceral adipose tissue (VAT) area. Glucose, insulin, adiponectin, leptin, and insulin resistance (IR) index were measured on days 1 and 12 after the onset of MI. New-onset type 2 diabetes was assessed 1 year after MI onset. RESULTS: According to computed tomography assessments of all study patients, 69 % of patients with MI suffered from visceral obesity. The VAT area was more closely associated with the risk of developing type 2 diabetes compared with the obesity parameters, BMI and WC. Patients with a VAT area greater than 130 cm(2) had a 3.6-fold higher risk of developing type 2 diabetes. The presence of IR and hyperleptinemia increased the risk of developing diabetes in the post-MI period 3.5 and 3.7 times, respectively, in patients with visceral obesity compared with patients without visceral obesity. CONCLUSION: Visceral obesity is associated with IR, a 5.7-fold increase in leptin levels and a high risk of developing type 2 diabetes 1 year after MI onset. BioMed Central 2016-03-17 /pmc/articles/PMC4794814/ /pubmed/26989445 http://dx.doi.org/10.1186/s13098-016-0136-6 Text en © Barbarash et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Barbarash, Olga
Gruzdeva, Olga
Uchasova, Evgenya
Dyleva, Yulia
Belik, Ekaterina
Akbasheva, Olga
Karetnikova, Victoria
Kokov, Alexander
The role of adipose tissue and adipokines in the manifestation of type 2 diabetes in the long-term period following myocardial infarction
title The role of adipose tissue and adipokines in the manifestation of type 2 diabetes in the long-term period following myocardial infarction
title_full The role of adipose tissue and adipokines in the manifestation of type 2 diabetes in the long-term period following myocardial infarction
title_fullStr The role of adipose tissue and adipokines in the manifestation of type 2 diabetes in the long-term period following myocardial infarction
title_full_unstemmed The role of adipose tissue and adipokines in the manifestation of type 2 diabetes in the long-term period following myocardial infarction
title_short The role of adipose tissue and adipokines in the manifestation of type 2 diabetes in the long-term period following myocardial infarction
title_sort role of adipose tissue and adipokines in the manifestation of type 2 diabetes in the long-term period following myocardial infarction
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794814/
https://www.ncbi.nlm.nih.gov/pubmed/26989445
http://dx.doi.org/10.1186/s13098-016-0136-6
work_keys_str_mv AT barbarasholga theroleofadiposetissueandadipokinesinthemanifestationoftype2diabetesinthelongtermperiodfollowingmyocardialinfarction
AT gruzdevaolga theroleofadiposetissueandadipokinesinthemanifestationoftype2diabetesinthelongtermperiodfollowingmyocardialinfarction
AT uchasovaevgenya theroleofadiposetissueandadipokinesinthemanifestationoftype2diabetesinthelongtermperiodfollowingmyocardialinfarction
AT dylevayulia theroleofadiposetissueandadipokinesinthemanifestationoftype2diabetesinthelongtermperiodfollowingmyocardialinfarction
AT belikekaterina theroleofadiposetissueandadipokinesinthemanifestationoftype2diabetesinthelongtermperiodfollowingmyocardialinfarction
AT akbashevaolga theroleofadiposetissueandadipokinesinthemanifestationoftype2diabetesinthelongtermperiodfollowingmyocardialinfarction
AT karetnikovavictoria theroleofadiposetissueandadipokinesinthemanifestationoftype2diabetesinthelongtermperiodfollowingmyocardialinfarction
AT kokovalexander theroleofadiposetissueandadipokinesinthemanifestationoftype2diabetesinthelongtermperiodfollowingmyocardialinfarction
AT barbarasholga roleofadiposetissueandadipokinesinthemanifestationoftype2diabetesinthelongtermperiodfollowingmyocardialinfarction
AT gruzdevaolga roleofadiposetissueandadipokinesinthemanifestationoftype2diabetesinthelongtermperiodfollowingmyocardialinfarction
AT uchasovaevgenya roleofadiposetissueandadipokinesinthemanifestationoftype2diabetesinthelongtermperiodfollowingmyocardialinfarction
AT dylevayulia roleofadiposetissueandadipokinesinthemanifestationoftype2diabetesinthelongtermperiodfollowingmyocardialinfarction
AT belikekaterina roleofadiposetissueandadipokinesinthemanifestationoftype2diabetesinthelongtermperiodfollowingmyocardialinfarction
AT akbashevaolga roleofadiposetissueandadipokinesinthemanifestationoftype2diabetesinthelongtermperiodfollowingmyocardialinfarction
AT karetnikovavictoria roleofadiposetissueandadipokinesinthemanifestationoftype2diabetesinthelongtermperiodfollowingmyocardialinfarction
AT kokovalexander roleofadiposetissueandadipokinesinthemanifestationoftype2diabetesinthelongtermperiodfollowingmyocardialinfarction